Fundies. English
Segment disclosures
Company overviewINVO BIOSCIENCE, INC.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
16 dimension combinations 75 retained observations 11 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Fertility Clinic Services
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=INVO:FertilityClinicServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 1621553 | USD | 20250520 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1537199 | USD | 20250520 | Open filing evidence |
Fertility Clinic Services · Revenue From External Customers
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=INVO:FertilityClinicServicesMember;srt:ProductOrServiceAxis=INVO:RevenueFromExternalCustomersMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 1621553 | USD | 20250520 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 1537199 | USD | 20250520 | Open filing evidence |
Invocell Device
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=INVO:InvocellDeviceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 20132 | USD | 20250520 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 39087 | USD | 20250520 | Open filing evidence |
Invocell Device · Inter Segment Revenue
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=INVO:InvocellDeviceMember;srt:ProductOrServiceAxis=INVO:InterSegmentRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 4500 | USD | 20250520 | Open filing evidence |
Invocell Device · Revenue From External Customers
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=INVO:InvocellDeviceMember;srt:ProductOrServiceAxis=INVO:RevenueFromExternalCustomersMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 15632 | USD | 20250520 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 39087 | USD | 20250520 | Open filing evidence |
Fertility Clinic Services · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=IVF:FertilityClinicServicesMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 2167785 | USD | 20260814 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 4150018 | USD | 20260814 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 1983540 | USD | 20260622 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 6721057 | USD | 20260602 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 5175870 | USD | 20251117 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1832094 | USD | 20260814 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 3453647 | USD | 20260814 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1621553 | USD | 20260622 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 6450431 | USD | 20260602 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 4763131 | USD | 20251117 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 3345120 | USD | 20250814 | Open filing evidence |
Fertility Clinic Services · Operating Segments · Revenue From External Customers
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=IVF:FertilityClinicServicesMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=IVF:RevenueFromExternalCustomersMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 2167785 | USD | 20260814 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 4150018 | USD | 20260814 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 1983540 | USD | 20260622 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 6721057 | USD | 20260602 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 5175870 | USD | 20251117 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 1832094 | USD | 20260814 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 3453647 | USD | 20260814 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 1621553 | USD | 20260622 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 6450431 | USD | 20260602 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 4763131 | USD | 20251117 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 3345120 | USD | 20250814 | Open filing evidence |
Invocell Device · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=IVF:InvocellDeviceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 7700 Restated | USD | 20260814 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 40692 Restated | USD | 20260814 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 44992 | USD | 20260622 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 147193 | USD | 20260602 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 101563 | USD | 20251117 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 31560 Restated | USD | 20260814 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 47192 Restated | USD | 20260814 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 20132 | USD | 20260622 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 110569 | USD | 20260602 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 102403 | USD | 20251117 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 82763 | USD | 20250814 | Open filing evidence |
Invocell Device · Operating Segments · Inter Segment Revenue
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=IVF:InvocellDeviceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=IVF:InterSegmentRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 2376 | USD | 20260814 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 14376 | USD | 20260814 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 12000 | USD | 20260622 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 27000 | USD | 20260602 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 19500 | USD | 20251117 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 9000 | USD | 20260814 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 13500 | USD | 20260814 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 4500 | USD | 20260622 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 29000 | USD | 20260602 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 19500 | USD | 20251117 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 15000 | USD | 20250814 | Open filing evidence |
Invocell Device · Operating Segments · Revenue From External Customers
Statement Business Segments · Consolidation Items · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=IVF:InvocellDeviceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=IVF:RevenueFromExternalCustomersMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 7700 | USD | 20260814 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 40692 | USD | 20260814 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 32992 | USD | 20260622 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 120193 | USD | 20260602 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 82063 | USD | 20251117 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 31560 | USD | 20260814 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 47192 | USD | 20260814 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 15632 | USD | 20260622 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 81569 | USD | 20260602 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 82903 | USD | 20251117 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 67763 | USD | 20250814 | Open filing evidence |
Fertility Clinic Services
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=NAYA:FertilityClinicServicesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 6450431 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2862574 | USD | 20250430 | Open filing evidence |
Fertility Clinic Services · Revenue From External Customers
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=NAYA:FertilityClinicServicesMember;srt:ProductOrServiceAxis=NAYA:RevenueFromExternalCustomersMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 6450431 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 2862574 | USD | 20250430 | Open filing evidence |
Invocell Device
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=NAYA:InvocellDeviceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 110569 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 158001 | USD | 20250430 | Open filing evidence |
Invocell Device · Inter Segment Revenue
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=NAYA:InvocellDeviceMember;srt:ProductOrServiceAxis=NAYA:InterSegmentRevenueMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 29000 | USD | 20250430 | Open filing evidence |
Invocell Device · Revenue From External Customers
Statement Business Segments · Product Or Service
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=NAYA:InvocellDeviceMember;srt:ProductOrServiceAxis=NAYA:RevenueFromExternalCustomersMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-12-31 | 81569 | USD | 20250430 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 158001 | USD | 20250430 | Open filing evidence |
All Other Segments
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | -4500 | USD | 20250520 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | -29000 | USD | 20250430 | Open filing evidence |